BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34642737)

  • 1. Outcomes of robotic low anterior resection versus transanal total mesorectal excision for rectal cancer.
    Buan JLB; So WZ; Lim XC; Chong CS
    BJS Open; 2021 Sep; 5(5):. PubMed ID: 34642737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of laparoscopic versus robot-assisted versus transanal total mesorectal excision surgery for rectal cancer: a retrospective propensity score-matched cohort study of short-term outcomes.
    Hol JC; Burghgraef TA; Rutgers MLW; Crolla RMPH; van Geloven NAW; Hompes R; Leijtens JWA; Polat F; Pronk A; Smits AB; Tuynman JB; Verdaasdonk EGG; Consten ECJ; Sietses C
    Br J Surg; 2021 Nov; 108(11):1380-1387. PubMed ID: 34370834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of transanal total mesorectal excision and robotic total mesorectal excision for low rectal cancer after neoadjuvant chemoradiotherapy.
    Shin JK; Kim HC; Yun SH; Park YA; Cho YB; Huh JW; Lee WY
    Surg Endosc; 2021 Dec; 35(12):6998-7004. PubMed ID: 33523275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of open vs laparoscopic vs robotic vs transanal total mesorectal excision (TME) for rectal cancer: a network meta-analysis.
    Seow W; Dudi-Venkata NN; Bedrikovetski S; Kroon HM; Sammour T
    Tech Coloproctol; 2023 May; 27(5):345-360. PubMed ID: 36508067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME).
    2017 European Society of Coloproctology (ESCP) collaborating group
    Colorectal Dis; 2018 Sep; 20 Suppl 6():33-46. PubMed ID: 30255642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and meta-analysis of robotic-assisted transabdominal total mesorectal excision and transanal total mesorectal excision: which approach offers optimal short-term outcomes for mid-to-low rectal adenocarcinoma?
    Butterworth JW; Butterworth WA; Meyer J; Giacobino C; Buchs N; Ris F; Scarpinata R
    Tech Coloproctol; 2021 Nov; 25(11):1183-1198. PubMed ID: 34562160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transanal versus conventional total mesorectal excision for rectal cancer using the IDEAL framework for implementation.
    Robertson RL; Karimuddin A; Phang T; Raval M; Brown C
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33889949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.
    Roodbeen SX; Penna M; Mackenzie H; Kusters M; Slater A; Jones OM; Lindsey I; Guy RJ; Cunningham C; Hompes R
    Surg Endosc; 2019 Aug; 33(8):2459-2467. PubMed ID: 30350103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robotic low anterior resection versus transanal total mesorectal excision in rectal cancer: A comparison of 115 cases.
    Perez D; Melling N; Biebl M; Reeh M; Baukloh JK; Miro J; Polonski A; Izbicki JR; Knoll B; Pratschke J; Aigner F
    Eur J Surg Oncol; 2018 Feb; 44(2):237-242. PubMed ID: 29249592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer.
    Rasulov AO; Mamedli ZZ; Gordeyev SS; Kozlov NA; Dzhumabaev HE
    Tech Coloproctol; 2016 Apr; 20(4):227-34. PubMed ID: 26794213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the short-term outcomes in lower rectal cancer using three different surgical techniques: Transanal total mesorectal excision (TME), laparoscopic TME, and open TME.
    Chen YT; Kiu KT; Yen MH; Chang TC
    Asian J Surg; 2019 Jun; 42(6):674-680. PubMed ID: 30318319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pathological outcomes after transanal versus laparoscopic total mesorectal excision: a prospective study using data from randomized control trial.
    Zeng Z; Luo S; Chen J; Cai Y; Zhang X; Kang L
    Surg Endosc; 2020 Sep; 34(9):3956-3962. PubMed ID: 31586244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological safety of transanal total mesorectal excision (TaTME) for rectal cancer: mid-term results of a prospective multicentre study.
    Simo V; Tejedor P; Jimenez LM; Hernan C; Zorilla J; Arrredondo J; Lapuente F; Pastor C
    Surg Endosc; 2021 Apr; 35(4):1808-1819. PubMed ID: 32333158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of early experience of robotic and transanal total mesorectal excision using propensity score matching.
    Law WL; Foo DCC
    Surg Endosc; 2019 Mar; 33(3):757-763. PubMed ID: 30014329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating a tumour appropriate transanal or robotic assisted approach to total mesorectal excision in high-volume rectal cancer practice is safe and cost-effective.
    Fleming C; Fernandez B; Boissieras L; Cauvin T; Denost Q
    J Robot Surg; 2023 Oct; 17(5):1979-1987. PubMed ID: 37099264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transanal vs laparoscopic total mesorectal excision for rectal cancer: initial experience from Denmark.
    Perdawood SK; Al Khefagie GA
    Colorectal Dis; 2016 Jan; 18(1):51-8. PubMed ID: 26603786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic total mesorectal excision or transanal total mesorectal excision meta-analysis.
    Chen MZ; Tay YK; Warrier SK; Heriot AG; Kong JC
    ANZ J Surg; 2021 Nov; 91(11):2269-2276. PubMed ID: 34553466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robotic vs. TaTME Rectal Surgery (ROTA STUDY) Matched Cohort Trial for Mid to Low Rectal Cancer Surgery Evaluation Trial in the Hands of an Experienced Surgeon.
    Jootun R; Cuk P; Ellebæk M; Andersen PV; Salomon S; Baatrup G; Al-Najami I; Khan J
    Int J Surg Protoc; 2022; 26(1):7-13. PubMed ID: 35280494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve.
    D'Andrea AP; McLemore EC; Bonaccorso A; Cuevas JM; Basam M; Tsay AT; Bhasin D; Attaluri V; Sylla P
    Surg Endosc; 2020 Sep; 34(9):4101-4109. PubMed ID: 31602515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transanal total mesorectal excision (TaTME): current status and future perspectives.
    Vignali A; Elmore U; Milone M; Rosati R
    Updates Surg; 2019 Mar; 71(1):29-37. PubMed ID: 30734896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.